Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Cardiovascular Medicine
Published in: Current Treatment Options in Cardiovascular Medicine 10/2023

Open Access 15-09-2023 | Cardiomyopathy

Exercise and Sports Participation in Children with Cardiomyopathy: A Review

Authors: Imran R. Masood, DO, Jonathan B. Edelson, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 10/2023

Login to get access

Abstract

Purpose of review

There are numerous health benefits to exercise, including improved cardiovascular, metabolic, and mental health. Despite these many benefits, children with cardiomyopathy have been traditionally restricted from engaging in exercise or participating in organized sports. The purpose of this review is to summarize the current literature regarding the utility of cardiopulmonary exercise testing, discuss the safety and benefits of exercise and sports participation in children with cardiomyopathy, and to identify research gaps in the field.

Recent findings

We highlight relevant literature discussing exercise and sports participation in children with hypertrophic cardiomyopathy, dilated cardiomyopathy, anthracycline-induced cardiomyopathy, and those with ventricular assist device support. We discuss recent literature describing methods for risk stratification.

Summary

The current literature globally favors promoting exercise and sports participation after appropriate risk stratification. Additionally, we offer guidance for how to safely promote exercise in children with cardiomyopathy.
Literature
1.
Li VL, He Y, Contrepois K, Liu H, Kim JT, Wiggenhorn AL, et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature. 2022;606(7915):785–90.PubMedPubMedCentralCrossRef
2.
Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 1991;34(12):891–8.
3.
Baumann FT, Bloch W, Beulertz J. Clinical exercise interventions in pediatric oncology: A systematic review. Vol. 74, Pediatr Res. 2013;366–74.
4.
Thijssen DHJ, Redington A, George KP, Hopman MTE, Jones H. Association of exercise preconditioning with immediate cardioprotection: A review. Vol. 3, JAMA Cardiology. Am Med Assoc. 2018;169–76.
5.
6.
Kvam S, Kleppe CL, Nordhus IH, Hovland A. Exercise as a treatment for depression: A meta-analysis. Vol. 202, Journal of Affective Disorders. Elsevier B.V.; 2016. p. 67–86.
7.
Penedo FJ, Dahn JR, Williams L. Exercise and well-being: A review of mental and physical health benefits associated with physical activity. Vol. 18, Curr Opin Psychiatry. 2005.
8.
Williams CF, Bustamante EE, Waller JL, Davis CL. Exercise effects on quality of life, mood, and self-worth in overweight children: The SMART randomized controlled trial. Transl Behav Med. 2019;9(3):451–9.PubMedPubMedCentralCrossRef
9.
Kemppainen J, Stolen K, Kalliokoski KK, Salo T, Karanko H, Viljanen T, et al. Exercise training improves insulin stimulated skeletal muscle glucose uptake independent of changes in perfusion in patients with dilated cardiomyopathy. J Card Fail. 2003;9(4):286–95.PubMedCrossRef
10.
Liang X, Tang J, Chao F lei, Zhang Y, Chen L mu, Wang F fei, et al. Exercise improves depressive symptoms by increasing the number of excitatory synapses in the hippocampus of CUS-induced depression model rats. Behav Brain Res. 2019;18:374.
11.
Schuch FB, Vancampfort D, Rosenbaum S, Richards J, Ward PB, Stubbs B. Exercise improves physical and psychological quality of life in people with depression: A meta-analysis including the evaluation of control group response. Vol. 241, Psychiatry Research. Elsevier Irel Ltd. 2016;47–54.
12.
McCaskie C, Siafarikas A, Cochrane Wilkie J, Sutton V, Chivers P, Hart NH, et al. The benefits to bone health in children and pre-school children with additional exercise interventions: A systematic review and meta-analysis. Vol. 15, Nutrients MDPI. 2023.
13.
Santos-Parker JR, LaRocca TJ, Seals DR. Aerobic exercise and other healthy lifestyle factors that influence vascular aging. Adv Physiol Educ. 2014;38(4):296–307.PubMedPubMedCentralCrossRef
14.
Christian S, Somerville M, Taylor S, Spence JC, Giuffre M, Atallah J. The impact of physical activity modification on the well-being of a cohort of children with an inherited arrhythmia or cardiomyopathy. Cardiol Young. 2020;30(5):692–7.PubMedCrossRef
15.
Khoury M, Wittekind S, Lal AK, Conway J, Bansal N, Lorts A, et al. Significant variation in exercise recommendations for youth with cardiomyopathies or Fontan circulation: An advanced cardiac therapies improving outcomes network learning survey. Circ Heart Fail. 2021.
16.
Whitehill RD, Balaji S, Kelleman M, Chandler SF, Abrams DJ, Mao C, et al. Exercise recommendations in pediatric HCM: Variation and influence of provider characteristics. Pediatr Cardiol. 2022;43(1):132–41.PubMedCrossRef
17.
Burstein DS, McBride M, Lorts A, Rosenthal D, Peng DM, Lantz J, et al. Variation in cardiac rehabilitation for pediatric ventricular assist device recipients across North America. ASAIO J. 2021;67(9):1045–50.PubMedCrossRef
18.
Kumar S, Kelly AS. Review of childhood obesity: From epidemiology, etiology, and comorbidities to clinical assessment and treatment. Vol. 92, Mayo Clinic Proceedings. Elsevier Ltd. 2017;251–65.
19.
Ogden CL, Carroll MD, Fryar CD, Flegal KM. Key findings data from the national health and nutrition examination survey. 2011.
20.
Conway J, Pidborochynski T, Khoury M, Dhillon SS, Vaujois L, Dallaire F, et al. Cardiovascular disease profile in children with HCM (aspire-HCM): A Canadian cross-sectional study. Circulation. 2022.
21.
Edelson JB, Stanley HM, Min J, Burstein DS, Lane-Fall M, O’Malley S, et al. Cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy. JACC: Advances. 2022;1(4):100107.
22.
Hebert JJ, Klakk H, Møller NC, Grøntved A, Andersen LB, Wedderkopp N. The prospective association of organized sports participation with cardiovascular disease risk in children (the CHAMPS study-DK). Mayo Clin Proc. 2017;92(1):57–65.PubMedCrossRef
23.
Spanaki A, O’Curry S, Winter-Beatty J, Mead-Regan S, Hawkins K, English J, et al. Psychosocial adjustment and quality of life in children undergoing screening in a specialist paediatric hypertrophic cardiomyopathy clinic. Cardiol Young. 2016;26(5):961–7.PubMedCrossRef
24.
25.
Ullal AJ, Abdelfattah RS, Ashley EA, Froelicher VF. Hypertrophic cardiomyopathy as a cause of sudden cardiac death in the young: A meta-analysis. Am J Med. 2016;129(5):486-496.e2.PubMedCrossRef
26.
Lipshultz SE, Orav EJ, Wilkinson JD, Towbin JA, Messere JE, Lowe AM, et al. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: An analysis of data from the Pediatric Cardiomyopathy Registry. The Lancet. 2013;382(9908):1889–97.CrossRef
27.
Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults . Circulation. 1995.
28.
Husser D, Ueberham L, Jacob J, Heuer D, Riedel-Heller S, Walker J, et al. Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany—An analysis of over 5 million patients. PLoS One. 2018;13(5).
29.
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. Diagnosis and management of hypertrophic cardiomyopathy: Updated guidelines from the ACC/AHA. Am Fam Physician. 2022;105(2):207–9.
30.
31.
Shah M. Hypertrophic cardiomyopathy. Vol. 27, Cardiology in the young. Cambridge University Press. 2017;S25–30.
32.
Weissler-Snir A, Allan K, Cunningham K, Connelly KA, Lee DS, Spears DA, et al. Hypertrophic cardiomyopathy-related sudden cardiac death in young people in Ontario. Circulation. 2019;140(21):1706–16.PubMedCrossRef
33.
Hwang J won, Lee SC, Kim D, Kim J, Kim EK, Chang SA, et al. Determinants of exercise capacity in patients with hypertrophic cardiomyopathy. J Korean Med Sci. 2022;37(8).
34.
Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes analysis of 1866 deaths in the united states, 1980–2006. Circulation. 2009;119(8):1085–92.PubMedCrossRef
35.
Finocchiaro G, Papadakis M, Robertus JL, Dhutia H, Steriotis AK, Tome M, et al. Etiology of sudden death in sports insights from a United Kingdom Regional Registry. 2016.
36.
Saberi S, Wheeler M, Bragg-Gresham J, Hornsby W, Agarwal PP, Attili A, et al. Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: A randomized clinical trial. JAMA - Journal of the American Medical Association. 2017;317(13):1349–57.PubMedCrossRef
37.
38.
Reineck E, Rolston B, Bragg-Gresham JL, Salberg L, Baty L, Kumar S, et al. Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. Am J Cardiol. 2013;111(7):1034–9.PubMedCrossRef
39.
Przybylski R, Fischer IR, Gauvreau K, Alexander ME, Shafer KM, Colan SD, et al. Assessment of exercise function in children and young adults with hypertrophic cardiomyopathy and correlation with transthoracic echocardiographic parameters. Pediatr Cardiol. 2022;43(5):1037–45.PubMedCrossRef
40.
41.
• Conway J, Min S, Villa C, Weintraub RG, Nakano S, Godown J, et al. The prevalence and association of exercise test abnormalities with sudden cardiac death and transplant-free survival in childhood hypertrophic cardiomyopathy. Circulation. 2022. This is a large multi-center study, that provided new insights, into the prognostic utility of CPET, specifically for children with HCM.
42.
Yasui K, Shibata T, Nishizawa T, Yokoyama U, Takigiku K, Sakon T, et al. Response of the stroke volume and blood pressure of young patients with nonobstructive hypertrophic cardiomyopathy to exercise. Jpn Circ J. 2001;65:300–4.PubMedCrossRef
43.
Rowland T. Cardiopulmonary exercise testing in children and adolescents. Champaign, IL: Human Kinetics; 2017. p. 44–44.
44.
MacNamara JP, Dias KA, Hearon CM, Hieda M, Turer AT, Link MS, et al. Limits to submaximal and maximal exercise in patients with hypertrophic cardiomyopathy. J Appl Physiol. 2022;133(4):787–97.PubMedCrossRef
45.
Jhaveri S, Komarlu R, Worley S, Shahbah D, Gurumoorthi M, Zahka K. Left atrial strain and function in pediatric hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2021;34(9):996–1006.PubMedCrossRef
46.
Kjaergaard J, Johnson BD, Pellikka PA, Cha SS, Oh JK, Ommen SR. Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2005;18(12):1373–80.PubMedCrossRef
47.
Magrì D, Santolamazza C. Cardiopulmonary exercise test in hypertrophic cardiomyopathy. In: Annals of the American Thoracic Society. Am Thoracic Soc. 2017. p. S102–9.
48.
• Sobierajski F, Storey K, Bird M, Anthony S, Pol S, Pidborochynski T, et al. Use of photovoice to explore pediatric patients with hypertrophic cardiomyopathy and their parents’ perceptions of a heart-healthy lifestyle. J Am Heart Assoc. 2022;11(7). This study provides new information of the specific psychological factors that teenagers with HCM face regarding exercise and sports participation.
49.
Balaji S, DiLorenzo MP, Fish FA, Etheridge SP, Aziz PF, Russell MW, et al. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study. Heart Rhythm. 2019;16(10):1462–7.PubMedCrossRef
50.
Kaski JP, Norrish G, Ding T, Field E, Ziółkowska L, Olivotto I, et al. Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM risk-kids). JAMA Cardiol. 2019;4(9):918–27.PubMedPubMedCentralCrossRef
51.
Miron A, Lafreniere-Roula M, Steve Fan CP, Armstrong KR, Dragulescu A, Papaz T, et al. A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. Circulation. 2020;142(3):217–29.PubMedPubMedCentralCrossRef
52.
Wittlieb-Weber CA, Cohen MS, McBride MG, Paridon SM, Morrow R, Wasserman M, et al. Elevated left ventricular outflow tract velocities on exercise stress echocardiography may be a normal physiologic response in healthy youth. J Am Soc Echocardiogr. 2013;26(12):1372–8.PubMedCrossRef
53.
Dejgaard LA, Haland TF, Lie OH, Ribe M, Bjune T, Leren IS, et al. Vigorous exercise in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2018;1(250):157–63.CrossRef
54.
Burstein DS, Gaynor JW, Griffis H, Ritter A, Connor MJO, Rossano JW, et al. Genetic variant burden and adverse outcomes in pediatric cardiomyopathy. Pediatr Res. 2021;89(6):1470–6.PubMedCrossRef
55.
Pollmann K, Kaltenecker E, Schleihauf J, Ewert P, Görlach A, Wolf CM. Compound mutation in cardiac sarcomere proteins is associated with increased risk for major arrhythmic events in pediatric onset hypertrophic cardiomyopathy. J Clin Med. 2021;10(22).
56.
Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, et al. Safety of sports for athletes with implantable cardioverter-defibrillators: Results of a prospective, multinational registry. Circulation. 2013;127(20):2021–30.PubMedCrossRef
57.
Maron BJ, Casey SA, Olivotto I, Sherrid M V., Semsarian C, Autore C, et al. Clinical course and quality of life in high-risk patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol. 2018;11(4).
58.
de Feria AE, Lin KY, Day SM. Applying shared decision making to sports participation for a patient with hypertrophic cardiomyopathy. JACC Case Rep. 2021;3(1):6–9.PubMedCrossRef
59.
Etheridge SP, Saarel EV, Martinez MW. Exercise participation and shared decision-making in patients with inherited channelopathies and cardiomyopathies. Heart Rhythm. 2018;15(6):915–20.PubMedCrossRef
60.
Wasserstrum Y, Barbarova I, Lotan D, Kuperstein R, Shechter M, Freimark D, et al. Efficacy and safety of exercise rehabilitation in patients with hypertrophic cardiomyopathy. J Cardiol. 2019;74(5):466–72.PubMedCrossRef
61.
McBride MG, Burstein DS, Edelson JB, Paridon SM. Cardiopulmonary rehabilitation in pediatric patients with congenital and acquired heart disease. Vol. 40, Journal of Cardiopulmonary Rehabilitation and Prevention. Lippincott Williams and Wilkins; 2020;370–7.
62.
Schultheiss HP, Fairweather DL, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019;5(1).
63.
64.
Sinagra G, Iorio A, Merlo M, Cannatà A, Stolfo D, Zambon E, et al. Prognostic value of cardiopulmonary exercise testing in idiopathic dilated cardiomyopathy. Int J Cardiol. 2016;15(223):596–603.CrossRef
65.
Giardini A, Fenton M, Andrews RE, Derrick G, Burch M. Peak oxygen uptake correlates with survival without clinical deterioration in ambulatory children with dilated cardiomyopathy. Circulation. 2011;124(16):1713–8.PubMedCrossRef
66.
Chen CK, Manlhiot C, Russell JL, Kantor PF, McCrindle BW, Conway J. The utility of cardiopulmonary exercise testing for the prediction of outcomes in ambulatory children with dilated cardiomyopathy. Transplantation. 2017;101(10):2455–60.PubMedCrossRef
67.
Klaassen SHC, Liu LCY, Hummel YM, Damman K, van der Meer P, Voors AA, et al. Clinical and hemodynamic correlates and prognostic value of VE/VCO2 slope in patients with heart failure with preserved ejection fraction and pulmonary hypertension. J Card Fail. 2017;23(11):777–82.PubMedCrossRef
68.
Pelliccia A, Solberg EE, Papadakis M, Adami PE, Biffi A, Caselli S, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: Position statement of the sport cardiology section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019;40(1):19–33.PubMedCrossRef
69.
Wittekind SG, Gerdes Y, Mays W, Chin C, Jefferies JL. Cardiac rehabilitation improves cardiometabolic health: In young patients with nonischemic dilated cardiomyopathy. Tex Heart Inst J. 2018;45(1):27–30.PubMedPubMedCentralCrossRef
70.
den Boer SL, Flipse DHK, van der Meulen MH, Backx APCM, du Marchie Sarvaas GJ, Ten Harkel ADJ, et al. Six-minute walk test as a predictor for outcome in children with dilated cardiomyopathy and chronic stable heart failure. Pediatr Cardiol. 2017;38(3):465–71.CrossRef
71.
72.
Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the childhood cancer survivor study cohort. BMJ (Online). 2009;339(7736):34.
73.
Jefferies JL, Mazur WM, Howell CR, Plana JC, Ness KK, Li Z, et al. Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Cancer. 2021;127(24):4646–55.PubMedCrossRef
74.
Jordan JH, Castellino SM, Meléndez GC, Klepin HD, Ellis LR, Lamar Z, et al. Left ventricular mass change after anthracycline chemotherapy. Circ Heart Fail. 2018;11(7).
75.
76.
Thomas R, Kenfield SA, Yanagisawa Y, Newton RU. Why exercise has a crucial role in cancer prevention, risk reduction and improved outcomes. Vol. 139, British Medical Bulletin. Oxford University Press. 2021;100–19.
77.
Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065–70.PubMedCrossRef
78.
Wolf CM, Reiner B, Kühn A, Hager A, Müller J, Meierhofer C, et al. Subclinical cardiac dysfunction in childhood cancer survivors on 10-years follow-up correlates with cumulative anthracycline dose and is best detected by cardiopulmonary exercise testing, circulating serum biomarker, speckle tracking echocardiography, and tissue Doppler imaging. Front Pediatr. 2020;31:8.
79.
Ness KK, Plana JC, Joshi VM, Luepker R V, Durand JB, Daniel, et al. Exercise intolerance, mortality, and organ system impairment in adult survivors of childhood cancer. J Clin Oncol [Internet]. 2019;38:29–42.
80.
Christiansen JR, Kanellopoulos A, Lund MB, Massey R, Dalen H, Kiserud CE, et al. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2015;62(8):1437–43.PubMedCrossRef
81.
82.
Tsuda T, Kernizan D, Glass A, D’Aloisio G, Hossain J, Quillen J. Cardiopulmonary exercise testing characterizes silent cardiovascular abnormalities in asymptomatic pediatric cancer survivors. Pediatr Cardiol. 2022.
83.
Bas O, Erdemir AG, Onur MR, Ozer N, Sener YZ, Aksu S, et al. Sarcopenia and anthracycline cardiotoxicity in patients with cancer. BMJ Support Palliat Care [Internet]. 2021;0:1–9. Available from: http://​spcare.​bmj.​com/​.
84.
85.
Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Sweeney FC, et al. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: A randomized controlled trial. Breast Cancer Res. 2018;20(1).
86.
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.PubMedPubMedCentralCrossRef
87.
Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, et al. Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: A scientific statement from the American Heart Association. Circulation. 2019;139(21):E997-1012.PubMedPubMedCentralCrossRef
88.
Friend AJ, Feltbower RG, Hughes EJ, Dye KP, Glaser AW. Mental health of long-term survivors of childhood and young adult cancer: A systematic review. Vol. 143, International Journal of Cancer. Wiley-Liss Inc. 2018. p. 1279–86.
89.
Rossano JW, Vanderpluym CJ, Peng DM, Hollander SA, Maeda K, Adachi I, et al. The Society of Thoracic Surgeons Pedimacs Annual report fifth annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report. Ann Thorac Surg [Internet]. 2021;112:1763–74. Available from: https://​doi.​org/​10.​1016/​j.​athoracsur.​2021.​10.​001.
90.
Peng DM, Yu S, Lowery R, Ventresco C, Cousino MK, St. Louis JD, et al. Self-reported quality of life in children with ventricular assist devices. Pediatr Transplant. 2022;26(4).
91.
Goldberg JF, Schlosser RS, Walrath JG, Morris SA, Elias BA, Price JF, et al. Improved 6 minute walk distance and brain-type natriuretic peptide after continuous-flow ventricular assist device placement in children. ASAIO J. 2019;65(7):725–30.PubMedCrossRef
92.
Burstein DS, McBride MG, Edelson JB, Rossano JW, O’Connor MJ, Lin KY, et al. Safety and feasibility of exercise rehabilitation in children with ventricular assist devices. Pediatr Cardiol. 2022;43(5):1029–36.PubMedCrossRef
93.
Burstein DS, McBride MG, Rossano JW, O’Connor MJ, Lin KY, Mascio CE, et al. Increasing pump speed during exercise training improves exercise capacity in children with ventricular assist devices. ASAIO J. 2021;67(4):449–56.PubMedCrossRef
94.
Yarlagadda V, Maeda K, Zhang Y, Chen S, Dykes JC, Gowen MA, et al. Temporary circulatory support in U.S. children awaiting heart transplantation. 2017.
95.
Hermsen JA, Opotowsky AR, Powell AW, Mays WA, Chin C, Shertzer JD, et al. Physical frailty is modifiable in young cardiac rehabilitation patients. Pediatr Cardiol. 2022;43(8):1799–810.PubMedCrossRef
96.
Budts W, Pieles GE, Roos-Hesselink JW, de La Garza MS, D’Ascenzi F, Giannakoulas G, et al. Recommendations for participation in competitive sport in adolescent and adult athletes with congenital heart disease (CHD): Position statement of the sports cardiology exercise section of the European Association of Preventive Cardiology (EAPC), the European Society of Cardiology (ESC) working group on adult congenital heart disease and the sports cardiology, physical activity and prevention working group of the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2020;41(43):4191–9.PubMedCrossRef
97.
Mehra MR, Cleveland JC, Uriel N, Cowger JA, Hall S, Horstmanshof D, et al. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: A study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021;23(8):1392–400.PubMedCrossRef
Metadata
Title
Exercise and Sports Participation in Children with Cardiomyopathy: A Review
Authors
Imran R. Masood, DO
Jonathan B. Edelson, MD
Publication date
15-09-2023
Publisher
Springer US
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 10/2023
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-023-01006-2

Other articles of this Issue 10/2023

Current Treatment Options in Cardiovascular Medicine 10/2023 Go to the issue

ReviewPaper

State-of-the-Art Review: Alcohol Septal Ablation in Hypertrophic Cardiomyopathy

ReviewPaper

Is Early Repolarization Syndrome a Risk for Sudden Cardiac Death in Young Athletes?

ReviewPaper

Valvular Heart Disease and Pregnancy: An Update

Correction

Correction to: An Evidence‑Based Update on Physiological Pacing

ReviewPaper

The Role of Supervised Exercise Therapy in the Management of Symptomatic Peripheral Artery Disease with Intermittent Claudication

ReviewPaper

COVID-19 Vaccine–Associated Myocarditis Considerations for Competitive Athletes